Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Timolol for intraocular pressure reduction in pediatric glaucoma
2012-001324-34Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of travoprost in Childhood Glaucoma (2 arms), sponsored by Alcon Inc. Started Feb 2013; status: completed.
02
Drugs
travoprost
03
Conditions
Childhood Glaucoma
Beyond the preview
Go deeper on 2012-001324-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001324-34.